Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Premier Inc. Survey: Hospitals’ COVID-19 Testing Capacity Must at Least Triple Before Elective Surgeries Can Fully Resume
Premier Inc. Survey: Hospitals’ COVID-19 Testing Capacity Must at Least Triple Before Elective Surgeries Can Fully Resume


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released new survey results finding that healthcare facilities need to expand their current COVID-19 testing capacity by

Charles River Laboratories Announces First-Quarter 2020 Results
Charles River Laboratories Announces First-Quarter 2020 Results


Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2020. For the quarter, revenue was $707.1 million, an increase of 17.0% from $604.6

Premier Inc. Puts Unmatched Insights at Clinicians’ Fingertips with Launch of Perinatal Quality Dashboard
Premier Inc. Puts Unmatched Insights at Clinicians’ Fingertips with Launch of Perinatal Quality Dashboard


Premier Inc. (NASDAQ: PINC) is advancing care for mothers and infants with the launch of its Perinatal Quality Dashboard that delivers self-service, actionable insights to support clinicians on the

Chemed Corporation to Present at the BofA Securities 2020 Virtual Health Care Conference
Chemed Corporation to Present at the BofA Securities 2020 Virtual Health Care Conference


Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020, at 3:00 PM (ET).



The presentation will be

Premier Inc. Reports Fiscal 2020 Third-Quarter Results
Premier Inc. Reports Fiscal 2020 Third-Quarter Results


Premier Inc. (NASDAQ: PINC) today reported financial results for the fiscal 2020 third quarter ended March 31, 2020.



All results presented in this press release reflect continuing operations

Acadia Healthcare Reports First Quarter 2020 Results
Acadia Healthcare Reports First Quarter 2020 Results


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2020, and provided an update on the impact of the COVID-19 pandemic.

Xencor to Host First Quarter 2020 Financial Results Webcast and Conference Call on May 7, 2020
Xencor to Host First Quarter 2020 Financial Results Webcast and Conference Call on May 7, 2020


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced that it will

Premier Inc. Data: As COVID-19 Cases Spike, Demand for Drugs Used to Treat Related, Co-Morbid Conditions Also Soars
Premier Inc. Data: As COVID-19 Cases Spike, Demand for Drugs Used to Treat Related, Co-Morbid Conditions Also Soars


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released new data finding that as COVID-19 cases peak, so does demand for drugs used to treat cardiovascular conditions

Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update


Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2020, highlighting revenue growth and financial strength, clinical pipeline developments and the company’s

Chemed Reports First-Quarter 2020 Results
Chemed Reports First-Quarter 2020 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I


Novocure (NASDAQ: NVCR) today announced that an abstract highlighting results from the EF-19 post-approval registry trial studying Optune for the treatment of recurrent GBM will be presented as a

Premier Inc. to Report Fiscal 2020 Third-Quarter Results and Host Conference Call Before Market Opens on May 5
Premier Inc. to Report Fiscal 2020 Third-Quarter Results and Host Conference Call Before Market Opens on May 5


Premier Inc. (NASDAQ: PINC) plans to report fiscal 2020 third-quarter financial results the morning of May 5, 2020, followed by a conference call at 8 a.m. ET to discuss the results.



Conference

Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting
Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting


Chemed Corporation (NYSE:CHE) announced today that the Company will hold its 2020 Annual Meeting of Stockholders in a virtual-only format due to public health concerns relating to the coronavirus

Premier Inc. Real-Time Technology Solution Tracks, Manages and Supports Treatment of COVID-19 Patients Across the Country
Premier Inc. Real-Time Technology Solution Tracks, Manages and Supports Treatment of COVID-19 Patients Across the Country


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is marshaling all its data and technology capabilities to provide real-time, integrated solutions that help make it easier for

Premier Inc. Survey: Isolation Gowns Replace N95 Masks as the Top Shortage Concern Among Hospitals and Health Systems Treating COVID-19 Patients
Premier Inc. Survey: Isolation Gowns Replace N95 Masks as the Top Shortage Concern Among Hospitals and Health Systems Treating COVID-19 Patients


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that isolation gowns surpassed N95 masks as the top personal protective equipment (PPE)

Chemed To Report First-Quarter 2020 Earnings April 28, Related Conference Call To Be Held On April 29
Chemed To Report First-Quarter 2020 Earnings April 28, Related Conference Call To Be Held On April 29


Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2020, on Tuesday, April 28, 2020, following the close of trading on the

Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call
Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call


Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2020 financial results on Thursday, May 7th, before the market opens. A conference call has been scheduled to

As COVID-19 Pushes Hospital Patients to Post-Acute Care Settings, Supply and Resource Needs Grow, Per Premier Inc. Survey
As COVID-19 Pushes Hospital Patients to Post-Acute Care Settings, Supply and Resource Needs Grow, Per Premier Inc. Survey


Senior nursing and assisted living facilities have limited personal protective equipment (PPE) to care for a greater volume of patients, according to a Premier Inc. survey – indicating a second

Novocure Provides Business Update Related to COVID-19
Novocure Provides Business Update Related to COVID-19


Novocure (NASDAQ: NVCR) today provided an update on its response to the global COVID-19 pandemic and an initial evaluation of the impact the pandemic may have on Novocure’s general business

Premier Inc. Pursues Crucial Strategies to Get Supplies, Enable Care Delivery During COVID-19
Premier Inc. Pursues Crucial Strategies to Get Supplies, Enable Care Delivery During COVID-19


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is coordinating across the industry to help solve the supply chain challenges presented by COVID-19. Success will rely on

Premier Inc. Survey: As COVID-19 Spreads to New Hotspots, Hospitals Should Prepare for up to a 17X Surge in Supply Demand
Premier Inc. Survey: As COVID-19 Spreads to New Hotspots, Hospitals Should Prepare for up to a 17X Surge in Supply Demand


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results quantifying the surge capacity needed for personal protective equipment (PPE) and other supplies

Premier Inc. Data Shows Drugs Essential to Providing Care for COVID-19 Patients Quickly Slipping into Shortage
Premier Inc. Data Shows Drugs Essential to Providing Care for COVID-19 Patients Quickly Slipping into Shortage


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released data finding that 15 drugs essential to providing care for COVID-19 patients are currently in or very near

Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology
Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology


Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in preclinical digital pathology software-as-a-service.

Gemeinsamer Bundesausschuss beschließt Aufnahme von TTFields in die Richtlinie Methoden Vertragsärztlicher Versorgung (MVV-RL)
Gemeinsamer Bundesausschuss beschließt Aufnahme von TTFields in die Richtlinie Methoden Vertragsärztlicher Versorgung (MVV-RL)


Novocure (NASDAQ: NVCR) gab heute bekannt, dass der Gemeinsame Bundesausschuss (G-BA) die Ergänzung der MVV-RL um die Methode Tumortherapiefelder (TTFields) beschlossen hat. Optune ist somit für

Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend™ XmAb® Antibody Technology in Investigational Antibodies to Treat COVID-19
Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend™ XmAb® Antibody Technology in Investigational Antibodies to Treat COVID-19


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced it has entered